-
Androstenediol analogs as ER-beta-selective SERMs.
Blizzard TA,
Gude C,
Morgan JD 2nd,
Chan W,
Birzin ET,
Mojena M,
Tudela C,
Chen F,
Knecht K,
Su Q,
Kraker B,
Mosley RT,
Holmes MA,
Sharma N,
Fitzgerald PM,
Rohrer SP,
Hammond ML.
Merck Research Laboratories, PO Box 2000, Rahway NJ 07065, USA. tim_blizzard@merck.com
A series of 19-substituted androstenediol derivatives was prepared. Some of the novel analogs were surprisingly potent and selective ligands for ER-beta.
PMID: 16309907 [PubMed - indexed for MEDLINE]
-
Cited by 2 PubMed Central articles